PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
Recently, psychedelic drugs have once again taken popular culture by storm.
From the psychedelic startup companies newly forming on Wall Street to a recent New York Timesarticle that claims "psychedelic drugs are closer to medicinal use," it seems that there is a renewed media and medical interest in acid (LSD), mushrooms (psilocybin), ecstasy (MDMA), ayahuasca, DMT (dimethyltryptamine), and ketamine.
Read moreCheck out this podcast— Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies Rick Doblin discusses the role of MDMA-guided psychotherapy in treating PTSD.
Rick shares the story of how he developed a passion for healing the brain with psychedelics and the 35-year journey he’s endured to build a growing non-profit organization. He also explains how to effectively work with drugs that have been aggressively stigmatized and politicized.
Read moreUpon the FDA approval of psychedelic medicine for psychiatric indications—such as MDMA for post-traumatic stress disorder or psilocybin for depression—psychiatric pharmacists in particular and all pharmacists generally, will play a pivotal role in the psychedelic medicine market in the US.
Read moreResearchers are looking at how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
Read morePsychedelic users say that even bad trips gave them ‘life-altering insights’, a small study finds.
Read morePsychedelics are promising treatments for mental illness. Dozens of new startups have sprung up to develop and deliver the drugs to patients in need.
Read moreWhy does nature produce hallucinogenic compounds? One study set out to uncover the answer... keep reading to find out more.
Read moreCheck out this Q&A with Beckley Psytech Director & Chair of Scientific Advisory Board, Lady Amanda Feilding.
Amanda Feilding has been called the ‘hidden hand’ behind the renaissance of psychedelic science. Her contribution to global drug policy reform and to opening the doors to scientific research has been pivotal and widely acknowledged.
Read moreThis study assessed the impact of lifetime psychedelic drug use on mental health in relation to the first strict lockdown adopted by various countries (April-July 2020).
The findings showed that regular users of psychedelic drugs had less psychological stress and some personality differences when compared to occasional users and non-users. This suggests that either the use of psychedelics might be a protective factor itself or people with certain previous traits are more prone to frequently using psychedelic drugs.
Read moreCheck out this forum with Tim Ferriss, Michael Pollan, and Dr. Matthew W. Johnson on psychedelics research and philanthropy.
Read more